Upper Limb Muscle Strength Models for Patients With Motor Impairment.
Launched by PÔLE SAINT HÉLIER · Sep 19, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how upper limb muscle strength works in people who have motor impairments caused by conditions like stroke, multiple sclerosis, or spinal cord injuries. The researchers want to create mathematical models that describe how much force these muscles can generate, which can help guide rehabilitation efforts and improve robotic assistance for patients. By learning more about the muscles' abilities in these patients, the study aims to make rehabilitation more effective and tailored to individual needs.
To participate, individuals must be between 18 and 85 years old and currently receiving treatment at the Saint-Hélier rehabilitation center for a stroke that happened more than 15 days ago, multiple sclerosis, or spinal cord injury. They should have some level of motor deficit in specific shoulder and elbow movements but cannot have certain conditions that could affect the testing, such as severe muscle spasticity or cognitive impairments. If eligible, participants can expect to take part in assessments that will help the researchers gather important information about their muscle strength. This study is currently recruiting participants, and your involvement could contribute to better rehabilitation methods for people with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged between 18 and 85
- • A patient who is a member or beneficiary of a social security scheme
- • Patients hospitalised at the Saint-Hélier rehabilitation centre for a stroke more than 15 days old, MS or SCI
- • Patients with a motor deficit ≤3/5 on the MRC (Medical Research Council) scale in both internal-external shoulder rotation and elbow flexion-extension.
- • Patient with voluntary consent to participate in this study.
- Exclusion Criteria:
- • Spasticity \>3/4 on the Aschworth scale in the shoulder abductor or elbow flexor muscles.
- • Cognitive impairment that may interfere with measurements (MOCA \< 20/30)
- • Presence of a pressure sore \> stage 2 at the ischial level
- • Recent trauma to limbs or spine
- • Decompensated heart disease or other unbalanced pathology which contraindicates or may hinder isokinetic testing.
- • Persons deprived of their liberty by a judicial or administrative decision
- • Pregnant women, women in labour or nursing mothers.
About Pôle Saint Hélier
Pôle Saint Hélier is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care, the organization collaborates with multidisciplinary teams to conduct rigorous studies that adhere to the highest ethical and scientific standards. Pôle Saint Hélier aims to contribute to the development of new treatments and therapies, leveraging its state-of-the-art facilities and expertise to foster a collaborative environment for researchers and healthcare professionals. Through its initiatives, Pôle Saint Hélier is poised to make significant contributions to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported